Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
2024-11-15 Purchase | 2024-11-18 08:30 am | Nuvectis Pharma Inc. | NVCT | BENTSUR RON Chairman & CEO 10% Owner | 20,000 | $4.92 | $98,400 | 3,266,424 (Direct) | View |
2024-05-14 Purchase | 2024-05-15 09:16 am | Nuvectis Pharma Inc. | NVCT | BENTSUR RON Chairman & CEO 10% Owner | 1,940 | $6.74 | $13,076 | 3,246,424 (Direct) | View |
2024-05-10 Purchase | 2024-05-13 08:51 am | Nuvectis Pharma Inc. | NVCT | BENTSUR RON Chairman & CEO 10% Owner | 2,000 | $6.4 | $12,800 | 3,244,484 (Direct) | View |
2024-03-18 Purchase | 2024-03-19 08:00 am | Nuvectis Pharma Inc. | NVCT | BENTSUR RON Chairman & CEO 10% Owner | 5,000 | $10.29 | $51,450 | 3,242,484 (Direct) | View |
2023-10-10 Purchase | 2023-10-12 4:05 pm | Nuvectis Pharma Inc. | NVCT | BENTSUR RON Chairman & CEO 10% Owner | 640 | $11.08 | $7,091 | 3,237,484 (Direct) | View |
2023-10-06 Purchase | 2023-10-10 08:30 am | Nuvectis Pharma Inc. | NVCT | BENTSUR RON Chairman & CEO 10% Owner | 1,080 | $11.21 | $12,105 | 3,236,844 (Direct) | View |
2023-10-04 Purchase | 2023-10-06 08:37 am | Nuvectis Pharma Inc. | NVCT | BENTSUR RON Chairman & CEO 10% Owner | 3,220 | $11.01 | $35,455 | 3,235,764 (Direct) | View |
2023-08-15 Purchase | 2023-08-16 4:05 pm | Nuvectis Pharma Inc. | NVCT | BENTSUR RON Chairman & CEO 10% Owner | 350 | $14.61 | $5,112 | 3,232,544 (Direct) | View |
2023-08-08 Purchase | 2023-08-11 6:07 pm | Nuvectis Pharma Inc. | NVCT | BENTSUR RON Chairman & CEO 10% Owner | 300 | $14.73 | $4,418 | 3,232,194 (Direct) | View |
2023-07-20 Purchase | 2023-07-24 4:45 pm | Nuvectis Pharma Inc. | NVCT | BENTSUR RON Chairman & CEO 10% Owner | 335 | $14.92 | $4,998 | 3,231,894 (Direct) | View |
2023-07-19 Purchase | 2023-07-20 06:30 am | Nuvectis Pharma Inc. | NVCT | BENTSUR RON Chairman & CEO 10% Owner | 200 | $14.33 | $2,866 | 3,231,559 (Direct) | View |
2023-07-07 Purchase | 2023-07-18 08:34 am | Nuvectis Pharma Inc. | NVCT | BENTSUR RON Chairman & CEO 10% Owner | 260 | $15.52 | $4,035 | 3,231,359 (Direct) | View |
2023-07-06 Purchase | 2023-07-07 08:03 am | Nuvectis Pharma Inc. | NVCT | BENTSUR RON Chairman & CEO 10% Owner | 320 | $14.88 | $4,762 | 3,231,099 (Direct) | View |
2023-06-26 Purchase | 2023-06-27 08:45 am | Nuvectis Pharma Inc. | NVCT | BENTSUR RON Chairman & CEO 10% Owner | 750 | $16.5 | $12,375 | 3,230,779 (Direct) | View |
2023-06-21 Purchase | 2023-06-22 08:42 am | Nuvectis Pharma Inc. | NVCT | BENTSUR RON Chairman & CEO 10% Owner | 500 | $17.88 | $8,940 | 3,230,029 (Direct) | View |
2023-06-07 Purchase | 2023-06-08 9:28 pm | Nuvectis Pharma Inc. | NVCT | BENTSUR RON Chairman & CEO 10% Owner | 350 | $17.45 | $6,108 | 3,229,529 (Direct) | View |
2023-05-31 Purchase | 2023-06-01 08:00 am | Nuvectis Pharma Inc. | NVCT | BENTSUR RON Chairman & CEO 10% Owner | 330 | $17.28 | $5,702 | 3,229,179 (Direct) | View |
2023-05-24 Purchase | 2023-05-26 09:29 am | Nuvectis Pharma Inc. | NVCT | BENTSUR RON Chairman & CEO 10% Owner | 200 | $17.49 | $3,498 | 3,228,849 (Direct) | View |
2023-05-16 Purchase | 2023-05-18 07:00 am | Nuvectis Pharma Inc. | NVCT | BENTSUR RON Chairman & CEO 10% Owner | 320 | $17.02 | $5,448 | 3,228,649 (Direct) | View |
2023-03-23 Purchase | 2023-03-27 08:21 am | Nuvectis Pharma Inc. | NVCT | BENTSUR RON Chairman & CEO 10% Owner | 230 | $12.13 | $2,790 | 3,228,329 (Direct) | View |
2023-03-21 Purchase | 2023-03-23 08:30 am | Nuvectis Pharma Inc. | NVCT | BENTSUR RON Chairman & CEO 10% Owner | 480 | $12.08 | $5,798 | 3,228,099 (Direct) | View |
2023-03-20 Purchase | 2023-03-21 4:05 pm | Beyond Air Inc. | XAIR | BENTSUR RON Director | 2,300 | $6.48 | $14,904 | 144,736 (Direct) | View |
2023-03-14 Purchase | 2023-03-16 4:45 pm | Nuvectis Pharma Inc. | NVCT | BENTSUR RON Chairman & CEO 10% Owner | 2,160 | $10.86 | $23,465 | 3,227,619 (Direct) | View |
2022-11-30 Purchase | 2022-11-30 5:43 pm | Nuvectis Pharma Inc. | NVCT | BENTSUR RON Chairman & CEO 10% Owner | 150 | $7.45 | $1,118 | 3,015,459 (Direct) | View |
2022-11-25 Purchase | 2022-11-29 4:31 pm | Nuvectis Pharma Inc. | NVCT | BENTSUR RON Chairman & CEO 10% Owner | 450 | $7.41 | $3,335 | 3,015,309 (Direct) | View |
2022-11-17 Purchase | 2022-11-21 08:39 am | Nuvectis Pharma Inc. | NVCT | BENTSUR RON Chairman & CEO 10% Owner | 750 | $7.2333 | $5,425 | 3,014,859 (Direct) | View |
2022-11-10 Purchase | 2022-11-16 08:30 am | Nuvectis Pharma Inc. | NVCT | BENTSUR RON Chairman & CEO 10% Owner | 1,000 | $7.07 | $7,070 | 3,014,109 (Direct) | View |
2022-09-28 Purchase | 2022-10-03 08:16 am | Nuvectis Pharma Inc. | NVCT | BENTSUR RON Chairman & CEO 10% Owner | 1,000 | $7.345 | $7,345 | 3,013,109 (Direct) | View |
2022-09-23 Purchase | 2022-09-27 08:44 am | Nuvectis Pharma Inc. | NVCT | BENTSUR RON Chairman & CEO 10% Owner | 1,500 | $7.85 | $11,775 | 3,012,109 (Direct) | View |
2022-09-01 Purchase | 2022-09-06 08:00 am | Nuvectis Pharma Inc. | NVCT | BENTSUR RON Chairman & CEO 10% Owner | 1,700 | $8.2935 | $14,099 | 3,010,609 (Direct) | View |
2022-08-23 Purchase | 2022-08-30 07:35 am | Nuvectis Pharma Inc. | NVCT | BENTSUR RON Chairman & CEO 10% Owner | 1,500 | $9.0467 | $13,570 | 3,008,909 (Direct) | View |
2022-08-18 Purchase | 2022-08-22 09:00 am | Nuvectis Pharma Inc. | NVCT | BENTSUR RON Chairman & CEO 10% Owner | 19,426 | $8.6855 | $168,725 | 3,007,409 (Direct) | View |
2022-08-11 Purchase | 2022-08-16 4:05 pm | Nuvectis Pharma Inc. | NVCT | BENTSUR RON Chairman & CEO 10% Owner | 19,669 | $8.4 | $165,220 | 2,987,983 (Direct) | View |
2022-06-30 Sale | 2022-07-05 4:44 pm | Beyond Air Inc. | XAIR | BENTSUR RON Director | 40,000 | $6.5276 | $261,104 | 142,436 (Direct) | View |
2022-06-28 Purchase | 2022-06-30 08:30 am | Nuvectis Pharma Inc. | NVCT | BENTSUR RON Chairman & CEO 10% Owner | 4,000 | $11.63 | $46,540 | 2,968,314 (Direct) | View |
2022-06-22 Purchase | 2022-06-27 08:31 am | Nuvectis Pharma Inc. | NVCT | BENTSUR RON Chairman & CEO 10% Owner | 700 | $12.09 | $8,462 | 2,964,314 (Direct) | View |
2022-05-26 Purchase | 2022-05-31 08:31 am | Nuvectis Pharma Inc. | NVCT | BENTSUR RON Chairman & CEO 10% Owner | 1,000 | $15.82 | $15,820 | 2,963,614 (Direct) | View |
2022-05-19 Purchase | 2022-05-23 08:32 am | Nuvectis Pharma Inc. | NVCT | BENTSUR RON Chairman & CEO 10% Owner | 1,200 | $16.73 | $20,070 | 2,962,614 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
2024-03-20 Option Award | 2024-03-21 9:01 pm | N/A 2034-03-20 | Beyond Air Inc. | XAIR | BENTSUR RON Director | 45,000 | $0 | 45,000 (Direct) | View |
2023-01-12 Option Award | 2023-01-13 5:04 pm | N/A N/A | Nuvectis Pharma Inc. | NVCT | BENTSUR RON Chairman & CEO 10% Owner | 210,000 | $0 | 3,225,459 (Direct) | View |